Concepedia

Yuanbin Ru

YR

Statistics

Publications

16

Citations

2.1K

H-Index

15

Active since

2009

Affiliations

University of Colorado Denver(Current)

University of Colorado Cancer Center

BioMarin (United States)

Windber Research Institute

The University of Texas MD Anderson Cancer Center

Yuanbin Ru is an author at University of Colorado Denver specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2009–2021

16

Publications

16

The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations

Yuanbin Ru, Katerina Kechris, Boris Tabakoff et al. · Nucleic Acids Research · 2014 · 774 citations · Full text

, , +16

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition

Junko Murai, Ying Feng, Guoying Karen Yu et al. · Oncotarget · 2016 · 292 citations · Full text

, , +13

Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas

Dezheng Huo, Hai Hu, Suhn K. Rhie et al. · JAMA Oncology · 2017 · 285 citations · Full text

, , +16

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell et al. · Oncotarget · 2017 · 227 citations · Full text

, , +17

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

Steven C. Smith, Alexander S. Baras, Garrett M. Dancik et al. · The Lancet Oncology · 2011 · 148 citations · Full text

, , +13

1–5 of 16